A kinetic-dynamic model to explain the relationship between high potency and slow onset time for neuromuscular blocking drugs
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
To account for experimental data showing increased onset time with increased potency of neuromuscular blocking drugs, a pharmacokinetic-pharmacodynamic model is presented. It is characterized by a finite concentration of receptors (R)in the effect compartment. Transfer from central to effect compartment is linearly related to concentration gradient. A sigmoid Emax model is used to describe the relationship between receptor occupancy and effect. Plasma concentrations found in the literature are used. Differential equations are solved numerically for equipotent doses of drugs of different potencies. Because the density of receptors constitutes a significant drain of drug molecules for potent drugs, the model predicts an inverse relationship between speed of onset and potency. The concentration of receptors in the effect compartment Rwhich best fits experimental data obtained in humans is 0.28 Μmol/L. With this value of R,onset times are prolonged when the ED95 (dose for 95% blockade) is less than 0.1 Μmol/kg. It is concluded that, in the development of a short-acting nondepolarizing neuromuscular blocking drug, agents having an ED95 of 0.1 Μmol/kg or greater appear more promising.
- W. C. Bowman, I. W. Rodger, J. Houston, R. J. Marshall, and I. McIndewar. Structure: action relationships among some deacetoxy analogues of pancuronium and vecuronium in the anesthetized cat.Anesthesiology 69:57–62 (1988).
- A. F. Kopman. Pancuronium, gallamine, and d-tubocurarine compared: Is speed of onset inversely related to drug potency?Anesthesiology 70:915–920 (1989).
- W. D. M. Paton and D. R. Waud. The margin of safety of neuromuscular transmission.J. Physiol 191:59–90 (1967).
- F. Donati. Onset of action of relaxants.Can. J. Anaesth. 35:S52-S58 (1988).
- L. B. Sheiner, D. R. Stanski, S. Vozeh, R. D. Miller, and J. Ham. Simultaneous modeling of pharmacokinetics and pharmacodynamics: Application to d-tubocurarine.Clin. Pharmacol. Ther. 25:358–371 (1979).
- E. Fuseau and L. B. Sheiner. Simultaneous modeling of pharmacokinetics and pharmacodynamics with a nonparametric pharmacodynamic model.Clin. Pharmacol. Ther. 35:733–741 (1984).
- J. D. Unadkat, F. Bartha. and L. B. Sheiner. Simultaneous modeling of pharmacokinetics and pharmacodynamics with nonparametric kinetic and dynamic models.Clin. Pharmacol. Ther. 40:86–93 (1986).
- W. A. Colburn. Simultaneous pharmacodynamic and pharmacokinetic modeling.J. Pharmacokin. Biopharm. 9:367–388 (1981).
- N. H. G. Holford and L. B. Sheiner. Understanding the dose-effect relationship: Clinical application of pharmacokinetic-pharmacodynamic models.Clin. Pharmacokin. 6:429–453 (1981).
- C. A. Shanks. Pharmacokinetics of nondepolarizing muscle relaxants applied to calculation of bolus and infusion dosage regimens.Anesthesiology 64:72–86 (1986).
- S. Ward, N. Boheimer, B. C. Weatherley, R. J. Simmonds, and T. A. Dopson. Pharmacokinetics of atracurium and its metabolites in patients with renal function, and in patients with renal failure.Br. J. Anaesth. 59:697–706, 1987.
- F. M. deBros, A. Lai, R. Scott, J. deBros, A. G. Batson, N. Goudsouzian, H. H. Ali, A. B. Cosimi, and J. J. Savarese. Pharmacokinetics and pharmacodynamics of atracurium during isoflurane anesthesia in normal and anephric patients.Anesth. Analg. 65:743–746 (1986).
- Y. J. Sohn, A. F. Bencini, A. H. J. Scaf, U. W. Kersten, and S. Agoston. Comparative pharmacokinetics and dynamics of vecuronium and pancuronium in anesthetized patients.Anesth. Analg. 65:233–239 (1986).
- A. F. Bencini, A. H. J. Scaf, Y. J. Sohn, C. Meistelman, A. Lienhart, U. W. Kersten, S. Schwarz, and S. Agoston. Disposition and urinary excretion of vecuronium bromide in anesthetized patients with normal renal function or renal failure.Anesth. Analg. 65:245–251 (1986).
- R. S. Matteo, K. Nishitateno, E. K. Pua, and S. Spector. Pharmacokinetics of d-tubocurarine in man: Effect of an osmotic diuretic on urinary excretion.Anesthesiology 52:335–338 (1980).
- R. S. Matteo, W. W. Backus, D. D. McDaniel, W. P. Brotherton, R. Abraham, and J. Diaz. Pharmacokinetics and pharmacodynamics of d-tubocurarine and metocurine in the elderly.Anesth. Analg. 64:23–29 (1985).
- B. N. Swerdlow and F. O. Holley. Intravenous anaesthetic agents. Pharmacokinetic-pharmacodynamic relationships.Clin. Pharmacokin. 12:79–110 (1987).
- D. J. Murray, M. P. Mehta, W. W. Choi, R. B. Forbes, M. D. Sokoll, S. D. Gergis, G. D. Rudd, and M. M. Abou-Donia. The neuromuscular blocking and cardiovascular effects of doxacurium chloride in patients receiving nitrous oxide narcotic anesthesia.Anesthesiology 69:472–477 (1988).
- S. J. Basta, J. J. Savarese, H. H. Ali, P. B. Embree, A. F. Schwarz, G. D. Rudd, and W. B. Wastila. Clinical pharmacology of doxacurium chloride. A new long-acting non depolarizing muscle relaxant.Anesthesiology 69:478–486 (1988).
- D. L. Dresner, S. J. Basta, H. H. Ali, A. F. Schwartz, P. A. Embree, W. A. Wargin, A. A. Lai, K. A. Brady, and J. J. Savarese. Pharmacokinetics and pharmacodynamics of doxacurium in young and elderly patients during isoflurane anesthesia.Anesth. Analg. 71:498–502 (1990).
- R. P. F. Scott and J. Norman. Doxacurium chloride: A preliminary clinical trial.Br. J. Anaesth. 62:373–377 (1989).
- N. Krieg, J. F. Crul, and L. H. D. J. Booij. Relative potency of ORG NC 45, pancuronium, alcuronium and tubocurarine in anaesthetized man.Br. J. Anaesth. 52:783–788 (1980).
- A. Williams, H. Gyasi, C. Melloni and D. R. Bevan. Clinical experience with ORG NC45 (norcuron) as the sole muscle relaxant.Can. Anaesth. Soc. J. 29:567–572 (1982).
- E. N. Robertson, L. H. D. J. Booij, R. J. Fragen, and J. F. Crul. Clinical comparison of atracurium and vecuronium (ORG NC 45).Br. J. Anaesth. 55:125–129 (1983).
- T. E. J. Healy, N. D. Pugh, B. Kay, T. Sivalingam, and H. V. Petts. Atracurium and vecuronium: effect of dose on the time of onset.Br. J. Anaesth. 58:620–624 (1986).
- R. K. Mirakhur, C. J. Ferres, R. S. J. Clarke, I. M. Ball, and J. W. Dundee. Clinical evaluation of ORG NC 45.Br. J. Anaesth. 55:119–124 (1983).
- K. R0rvik, P. Husby, L. Gramstad, J. S. Vamnes, L. Bitsch-Larsen, and M. E. Koller. Comparison of large dose of vecuronium with pancuronium for prolonged neuromuscular blockade.Br. J. Anaesth. 61:180–185 (1988).
- A. Bencini and D. E. F. Newton. Rate of onset of good intubating conditions, respiratory depression and hand muscle paralysis after vecuronium.Br. J. Anaesth. 56:959–965 (1984).
- B. Ginsberg, P. S. Glass, T. Quill, D. Shafron, and K. D. Ossey. Onset and duration of neuromuscular blockade following high-dose vecuronium administration.Anesthesiology 71:201–205 (1989).
- M. R. Fahey, R. B. Morris, R. D. Miller, Y. J. Sohn, R. Cronnelly, and P. Gencarelli. Clinical pharmacology of ORG NC45 (Norcuron-TM: A new nondepolarizing muscle relaxant.Anesthesiology 55:6–11 (1981).
- K. Peper, R. J. Bradley, and F. Dreyer. The acetylcholine receptor at the neuromuscular junction.Physiol. Rev. 62:1271–1340 (1982).
- D. R. Bevan, J. C. Bevan, and F. Donati.Muscle Relaxants in Clinical Anesthesia, Year Book Medical Publishers, Chicago, 1988.
- F. Donati, J. Lahoud, C. M. Walsh, P. A. Lavelle, and D. R. Bevan. Onset of pancuronium and d-tubocurarine with priming.Can. Anaesth. Soc. J. 33:571–577 (1986).
- N. J. N. Harper, E. G. Bradshaw, and T. E. J. Healy. Evoked electromyographic and mechanical responses of the adductor pollicis compared during onset of neuromuscular blockade by atracurium or alcuronium, and during antagonism by neostigmine.Br. J. Anaesth. 58:1278–1284 (1986).
- J. Minsaas and J. Stovner. Artery-to-muscle onset time for neuromuscular blocking drugs.Br. J. Anaesth. 52:403–407 (1980).
- J. M. K. H. Wierda, A. P. De Wit, K. Kuizenga, and S. Agoston. Clinical observations on the neuromuscular blocking action of ORG 9426, a new steroidal non-depolarizing agent.Br. J. Anaesth. 64:521–523 (1990).
- G. A. Harrison and F. Junius. The effect of circulation time on the neuromuscular action of suxamethonium.Anaesth. Intensive Care 1:33–40 (1972).
- J. C. Scott, K. V. Ponganis, and D. R. Stanski. EEG quantitation of narcotic effect: The comparative pharmacodynamics of fentanyl and alfentanil.Anesthesiology 62: 234–241 (1985).
- A kinetic-dynamic model to explain the relationship between high potency and slow onset time for neuromuscular blocking drugs
Journal of Pharmacokinetics and Biopharmaceutics
Volume 19, Issue 5 , pp 537-552
- Cover Date
- Print ISSN
- Online ISSN
- Kluwer Academic Publishers-Plenum Publishers
- Additional Links
- neuromuscular blocking drugs
- onset time
- Industry Sectors